Physician Profile

Mark L. Metersky, M.D.

Professor of Medicine
Medical Director, UConn Center for Bronchiectasis Care
Director, Pulmonary and Critical Care Fellowship Program
Office Locations:

Pulmonary Medicine
UConn Health
263 Farmington Avenue
Farmington, CT 06030
860-679-8300
Directions

Board Certifications:
  • Internal Medicine
  • Pulmonary Disease
  • Critical Care Medicine
  • Sleep Medicine
Education and Training:
TrainingInstitutionMajor/Specialty
Undergraduate SchoolFranklin and Marshall CollegeBiology
Medical SchoolNew York University School of MedicineMedicine
FellowshipUniversity of California San Diego Medical CenterPulmonary and Critical Care Medicine
InternshipBoston City HospitalInternal Medicine
ResidencyBoston City HospitalInternal Medicine
Hospital Affiliation:
  • John Dempsey Hospital
Selected Publications:


Peer Reviewed Publications

New therapeutic options for noncystic fibrosis bronchiectasis. Yap, Vanessa L; Metersky, Mark L. (2015). Current opinion in infectious diseases, 2, (28), 171-6.

Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. Mortensen, Eric M; Halm, Ethan A; Pugh, Mary Jo; Copeland, Laurel A; Metersky, Mark; Fine, Michael J; Johnson, Christopher S; Alvarez, Carlos A; Frei, Christopher R; Good, Chester; Restrepo, Marcos I; Downs, John R; Anzueto, Antonio. (2014). JAMA, 21, (311), 2199-208.

Nebulized colistin for non-cystic fibrosis bronchiectasis: déjà vu all over again?. Metersky, Mark L; O'Donnell, Anne E. (2014). American journal of respiratory and critical care medicine, 10, (189), 1151-2.

National trends in patient safety for four common conditions, 2005-2011. Wang, Yun; Eldridge, Noel; Metersky, Mark L; Verzier, Nancy R; Meehan, Thomas P; Pandolfi, Michelle M; Foody, JoAnne M; Ho, Shih-Yieh; Galusha, Deron; Kliman, Rebecca E; Sonnenfeld, Nancy; Krumholz, Harlan M; Battles, James. (2014). The New England journal of medicine, 4, (370), 341-51.

The effect of the endothelin-1 receptor antagonist, bosentan, on patients with poorly controlled asthma: a 17-week, double-blind, placebo-controlled crossover pilot study. Coyle, Timothy B; Metersky, Mark L. (2013). The Journal of asthma : official journal of the Association for the Care of Asthma, 4, (50), 433-7.